Skip to main content
Investigation of the effects of thulium oxide nanoparticles and anti-cancer drugs on tumorous 9L gliosarcoma and MDCK non cancerous cells using micro-beams monitored by the x-tream dosimetry system and characterisation of DNA damage-repair with yH2AX
Grant